Group 3 Pulmonary Hypertension
Showing 1 - 25 of >10,000
Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)
Not yet recruiting
- Group 3 Pulmonary Hypertension
- recombinant human brain natriuretic peptide
- Placebo
- (no location specified)
Jan 30, 2023
COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)
Terminated
- COPD
- +2 more
- Inhaled Nitric Oxide 30mcg/kg IBW/hr
-
Edegem, BelgiumAntwerp University Hospital
Aug 9, 2022
Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via
Completed
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled NO delivered via INOpulse DS-C Device
- Placebo delivered via INOpulse DS-C Device
-
Jasper, Alabama
- +42 more
Jul 13, 2022
Pulmonary Hypertension Trial in Vienna (Aria CV Acute PH System)
Recruiting
- Pulmonary Hypertension
- Aria CV Acute PH System
-
Vienna, AustriaMedical University of Vienna
Mar 14, 2022
Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension Trial in Durham (Hyperpolarized 129Xe)
Not yet recruiting
- Interstitial Lung Disease
- +2 more
- Hyperpolarized 129Xe
-
Durham, North CarolinaDuke University Medical Center
Jan 14, 2022
Sarcoidosis-associated Pulmonary Hypertension Trial in Worldwide (Selexipag, Placebo)
Active, not recruiting
- Sarcoidosis-associated Pulmonary Hypertension
- Selexipag
- Placebo
-
Indianapolis, Indiana
- +38 more
Jan 31, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Atrial Fibrillation, Pulmonary Hypertension Trial in Novosibirsk (Pulmonary vein isolation, Sham pulmonary artery denervation,
Recruiting
- Atrial Fibrillation
- Pulmonary Hypertension
- Pulmonary vein isolation
- +2 more
-
Novosibirsk, Russian FederationE. Meshalkin National Medical Research Center
May 3, 2023
Group 2 Pulmonary Hypertension, Heart Failure Trial (Gradient Denervation System)
Not yet recruiting
- Group 2 Pulmonary Hypertension
- Heart Failure
- Gradient Denervation System
- (no location specified)
Sep 18, 2023
Pulmonary Hypertension (World Health Organization Group 2), Heart Failure Trial (AZD3427, Placebo)
Not yet recruiting
- Pulmonary Hypertension (World Health Organization Group 2)
- Heart Failure
- AZD3427
- Placebo
- (no location specified)
Feb 17, 2023
Pulmonary Hypertension With AI and Echo
Not yet recruiting
- Pulmonary Hypertension
- Artificial intelligence tool for transthoracic echocardiography
-
Bath, United KingdomRoyal United Hospitals Bath NHS Foundation Trust
Nov 16, 2023
Hypertension, Pulmonary, Pulmonary Thromboembolisms Trial in Montreal (Measurement of pulmonary functional capillary surface
Recruiting
- Hypertension, Pulmonary
- Pulmonary Thromboembolisms
- Measurement of pulmonary functional capillary surface area
-
Montreal, Quebec, CanadaDavid Langleben
Jan 30, 2023
Pulmonary Arterial Hypertension Trial (Sotatercept)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- (no location specified)
Apr 5, 2023
Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)
Terminated
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled treprostinil solution
- Placebo solution
-
Birmingham, Alabama
- +75 more
Jan 5, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Pulmonary Arterial Hypertension Trial in Gothenburg (CS1 Administration)
Recruiting
- Pulmonary Arterial Hypertension
- CS1 Administration
-
Gothenburg, SwedenNiklas Bergh
Dec 5, 2022
Pulmonary Artery Hypertension Trial in Worldwide (GB002 (seralutinib), Placebo, Generic Dry Powder Inhaler)
Active, not recruiting
- Pulmonary Artery Hypertension
- GB002 (seralutinib)
- +2 more
-
Phoenix, Arizona
- +64 more
Aug 17, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Imatinib, Sildenafil, Bosentan)
Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Heidelberg (exercise and respiratory therapy,
Recruiting
- Pulmonary Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
- exercise and respiratory therapy
- sedentary control group
-
Heidelberg, Baden-Wuerttemberg, GermanyThoraxclinic at the University Hospital Heidelberg
Jul 12, 2022
Diaphragmatic Function as a Biomarker
Not yet recruiting
- Dyspnea; Asthmatic
- +5 more
- Diaphragm Ultrasound
- +13 more
- (no location specified)
Jun 5, 2023
Pulmonary Hypertension Due to Left Heart Disease Trial in Washington, Columbus, Pittsburgh (Treprostinil Diolamine)
Not yet recruiting
- Pulmonary Hypertension Due to Left Heart Disease
- Treprostinil Diolamine
-
Washington, District of Columbia
- +2 more
May 10, 2022
Improving Pulmonary Hypertension Screening by Echocardiography
Not yet recruiting
- Pulmonary Hypertension
- Transthoracic echocardiogram
-
Bath, Banes, United Kingdom
- +4 more
Sep 12, 2023
Heart Failure, Pulmonary Hypertension Trial in Vancouver, Ottawa (Rivet Shunt)
Not yet recruiting
- Heart Failure
- Pulmonary Hypertension
- Rivet Shunt
-
Vancouver, British Columbia, Canada
- +1 more
Sep 26, 2022